Acumen Pharmaceuticals, Inc. (ABOS) vs Anavex Life Sciences Corp. (AVXL)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Anavex Life Sciences Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.00HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
AVXL
Anavex Life Sciences Corp.
$1.64HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
Total return — ABOS vs AVXL
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)AVXL -93.3% (-41.8%/yr)ABOS compounded faster over this window
ABOS AVXL
ABOS vs AVXL: by the numbers
- •AVXL is the larger company ($152M vs $144M market cap).
Metrics side by side
Valuation
| Metric | ABOS | AVXL |
|---|---|---|
| P/B ratio | 2.52 | 1.35 |
Profitability
| Metric | ABOS | AVXL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -21.38% |
| ROIC | -118.67% | -27.25% |
Growth (annualized)
| Metric | ABOS | AVXL |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -37.74% |
Frequently asked
- How have ABOS and AVXL total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and AVXL delivered -37.74% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.